AI assistant
ABEONA THERAPEUTICS INC. — Director's Dealing 2021
Oct 4, 2021
33413_dirs_2021-10-04_6cb02789-7eb6-4cb4-a7f3-b2e781780306.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ABEONA THERAPEUTICS INC. (ABEO)
CIK: 0000318306
Period of Report: 2021-09-30
Reporting Person: Amoroso Michael (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-09-30 | Common stock | S | 45409 | $1.0875 | Disposed | 604637 | Direct |
Footnotes
F1: The sales reported in this Form 4 were to cover tax obligations associated with vested restricted stock awards and were effected pursuant to a Rule 10b5-1 trading plan adopted by Michael Amoroso on February 24, 2021.
F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.08 to $1.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote.